0001209191-21-033807.txt : 20210518
0001209191-21-033807.hdr.sgml : 20210518
20210518201203
ACCESSION NUMBER: 0001209191-21-033807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210518
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cheng Andrew
CENTRAL INDEX KEY: 0001778307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 21937993
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY, 3RD FLOOR
STREET 2: C/O AKERO THERAPEUTICS, INC.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
STREET 2: 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
STREET 2: 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-18
0
0001831828
Vera Therapeutics, Inc.
VERA
0001778307
Cheng Andrew
C/O VERA THERAPEUTICS, INC.
170 HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Class A Common Stock
2021-05-18
4
C
0
17488
A
17488
I
See footnote
Series C Preferred Stock
2021-05-18
4
C
0
17488
0.00
D
Class A Common Stock
17488
0
I
See footnote
The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
The shares are held of record by Andrew K. Cheng, as Trustee of the Andrew Cheng 2010 Trust UA 10-26-2010.
/s/ Joseph R. Young, Attorney-in-Fact
2021-05-18